Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Hydroxyurea Reduces Neutrophil Extracellular Trap Formation in Myeloproliferative Neoplasms

Ernesto J Cuenca, Nieves García Gisbert, BSc, Ascensión M de Los Reyes-García, PhDStudent, Cristina Aroca, MD, Lorena Martinez-Montesinos, MD, Marcio Andrade, MD PhD, Sonia Aguila, PhD, Pedro J Guijarro-Carrillo, Rosa Cifuentes-Riquelme, PhDStudent, Rocio González-Conejero, PhD, Constantino Martínez, PhD, Vicente Vicente, MD PhD, Alberto Alvarez-Larrán, MD, Beatriz Bellosillo, PhD, Raul Teruel-Montoya, PhD, Francisca Ferrer Marin, MD PhD

Blood (2020) 136 (Supplement 1): 20–21.

https://doi.org/10.1182/blood-2020-139368

Published: 2020

Journal Articles

Strategies for Analysis of Novel Molecular Variants in the RUNX1 Gene As a Cause of Familial Platelet Disorder with Predisposition to Acute Myeloid Leukemia (FPD/AML)

Veronica Palma-Barqueros, MSc, Jf Ruiz-Pividal, MSc, Jose Maria Bastida, MD PhD, Natalia Bohdan, MJ Lopez-Andreu, PhD, Raul Teruel-Montoya, PhD, Ana Isabel Antón, PhD, Francisca Ferrer Marin, MD PhD, Jose Padilla, Rosa Cifuentes-Riquelme, A Marín-Quilez, MSc, Marta Martín Izquierdo, MSc, Rocio Benito, PhD, Vicente Vicente, MD PhD, Jesus Maria . Hernández-Rivas, MD, José Ramón González-Porras, MD PhD, Jose Rivera, PhD, Maria Luisa Lozano, MD PhD

Blood (2019) 134 (Supplement_1): 2359.

https://doi.org/10.1182/blood-2019-128736

Published: 2019

Journal Articles

Different Clinical Implications of Kinase Domain BCR-ABL1 Variants Detected in Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia Patients

Blood (2019) 134 (Supplement_1): 5368.

https://doi.org/10.1182/blood-2019-127069

Published: 2019

Journal Articles

Clinical Characteristics and Cardioavscular Events in Patients with Esential Thrombocythemia with <10% Vs. ≥10% JAK2 V617F Allele Burden

Blood (2019) 134 (Supplement_1): 4171.

https://doi.org/10.1182/blood-2019-126980

Published: 2019

Journal Articles

Excess Mortality in Polycythemia Vera and Essential Thrombocythemia

Arturo Pereira, MD PhD, Carlos Besses Raebel, MD PhD, Juan Carlos Hernandez Boluda, MD PhD, Francisca Ferrer Marin, MD PhD, Carmen Garcia-Hernandez, MD, María Teresa Gómez-Casares, MD PhD, Manuel Pérez-Encinas, MD, María-Soledad Noya, MD, Beatriz Cuevas, MD, Gonzalo Caballero, MD, Maribel Mata, Francisco Cervantes, MD PhD, Alberto Alvarez-Larrán, MD PhD

Blood (2018) 132 (Supplement 1): 3042.

https://doi.org/10.1182/blood-2018-99-109892

Published: 2018

Journal Articles

Feasibility of Treatment Discontinuation in Chronic Myeloid Leukemia in Clinical Practice in Spain: Results from a Nationwide Series of 236 Patients

Blood (2018) 132 (Supplement 1): 47.

https://doi.org/10.1182/blood-2018-99-109976

Published: 2018

Journal Articles

rs2431697, a Polymorphism of Mir-146a, Is a Precozing Marker of Progression to Secondary Myelofibrosis: New Epigenetic Regulation of Jak/Stat3 Signaling

Blood (2018) 132 (Supplement 1): 3072.

https://doi.org/10.1182/blood-2018-99-119221

Published: 2018

Journal Articles

Deubiquitnase BAP1 Downregulation in Myeloid Malignances: A New Pathogenic Mechanism, Dominant in Chronic Myelomonocytic Leukemia

Ana Maria Hurtado, Eva Caparrós, Jose Miguel Torregrosa, Ginés Luengo, Mara Toderici, María Eugenia De la Morena, Begoña Muiña, Maria Luisa Lozano, Constant Martinez, Mari Luz Amigo, Felipe De Arriba, Francisco Ortuño, Raul Teruel Montoya, PhD, Francisca Ferrer-Marin, MD, PhD, Vicente Vicente, MD PhD, Andres Jerez, MD PhD

Blood (2014) 124 (21): 5594.

https://doi.org/10.1182/blood.V124.21.5594.5594

Published: 2014

Journal Articles

Developmental Differences In the Let-7b/IMP-1/IGF-II Axis contribute to the High Proliferative Rate of Neonatal Megakaryocyte Progenitors.

Ravi K. Gutti, PhD, Hannes Sallmon, Zhi-Jian Liu, PhD, Francisca Ferrer-Marin, MD, PhD, Alan Cantor, MD, PhD, Matthew Bailey, BS, Martha Sola-Visner, MD

Blood (2010) 116 (21): 1598.

https://doi.org/10.1182/blood.V116.21.1598.1598

Published: 2010

Journal Articles

Neonatal Megakaryocytes Do Not Mature Normally In the Absence of Thrombopoietin In Vivo: Potential Role of Developmental Differences In CXCR4 Expression

Francisca Ferrer-Marin, MD, PhD, Ravi K. Gutti, Ph.D., Zhi-Jian Liu, Ph.D., Joseph Italiano, Ph.D., Zhongbo Hu, MD, PhD, William Slayton, MD, Martha Sola-Visner, MD

Blood (2010) 116 (21): 88.

https://doi.org/10.1182/blood.V116.21.88.88

Published: 2010

NARROW

Hydroxyurea Reduces Neutrophil Extracellular Trap Formation in Myeloproliferative Neoplasms

Strategies for Analysis of Novel Molecular Variants in the RUNX1 Gene As a Cause of Familial Platelet Disorder with Predisposition to Acute Myeloid Leukemia (FPD/AML)

Different Clinical Implications of Kinase Domain BCR-ABL1 Variants Detected in Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia Patients

Clinical Characteristics and Cardioavscular Events in Patients with Esential Thrombocythemia with <10% Vs. ≥10% JAK2 V617F Allele Burden

Excess Mortality in Polycythemia Vera and Essential Thrombocythemia

Feasibility of Treatment Discontinuation in Chronic Myeloid Leukemia in Clinical Practice in Spain: Results from a Nationwide Series of 236 Patients

rs2431697, a Polymorphism of Mir-146a, Is a Precozing Marker of Progression to Secondary Myelofibrosis: New Epigenetic Regulation of Jak/Stat3 Signaling

Deubiquitnase BAP1 Downregulation in Myeloid Malignances: A New Pathogenic Mechanism, Dominant in Chronic Myelomonocytic Leukemia

Developmental Differences In the Let-7b/IMP-1/IGF-II Axis contribute to the High Proliferative Rate of Neonatal Megakaryocyte Progenitors.

Neonatal Megakaryocytes Do Not Mature Normally In the Absence of Thrombopoietin In Vivo: Potential Role of Developmental Differences In CXCR4 Expression

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only